全文获取类型
收费全文 | 257069篇 |
免费 | 39937篇 |
国内免费 | 2290篇 |
专业分类
耳鼻咽喉 | 4466篇 |
儿科学 | 5631篇 |
妇产科学 | 6978篇 |
基础医学 | 25818篇 |
口腔科学 | 8309篇 |
临床医学 | 44622篇 |
内科学 | 54036篇 |
皮肤病学 | 7369篇 |
神经病学 | 23529篇 |
特种医学 | 11541篇 |
外科学 | 38836篇 |
综合类 | 2276篇 |
现状与发展 | 45篇 |
一般理论 | 81篇 |
预防医学 | 22709篇 |
眼科学 | 6296篇 |
药学 | 14414篇 |
中国医学 | 1601篇 |
肿瘤学 | 20739篇 |
出版年
2024年 | 591篇 |
2023年 | 5649篇 |
2022年 | 3091篇 |
2021年 | 7354篇 |
2020年 | 7531篇 |
2019年 | 5418篇 |
2018年 | 10988篇 |
2017年 | 10330篇 |
2016年 | 11758篇 |
2015年 | 13318篇 |
2014年 | 16971篇 |
2013年 | 20165篇 |
2012年 | 16008篇 |
2011年 | 15575篇 |
2010年 | 13922篇 |
2009年 | 15197篇 |
2008年 | 12606篇 |
2007年 | 11422篇 |
2006年 | 11837篇 |
2005年 | 10007篇 |
2004年 | 8554篇 |
2003年 | 7309篇 |
2002年 | 6371篇 |
2001年 | 6325篇 |
2000年 | 5258篇 |
1999年 | 5074篇 |
1998年 | 3586篇 |
1997年 | 3222篇 |
1996年 | 3195篇 |
1995年 | 2821篇 |
1994年 | 2045篇 |
1993年 | 1726篇 |
1992年 | 2439篇 |
1991年 | 2341篇 |
1990年 | 1984篇 |
1989年 | 1859篇 |
1988年 | 1744篇 |
1987年 | 1485篇 |
1986年 | 1443篇 |
1985年 | 1283篇 |
1984年 | 969篇 |
1983年 | 932篇 |
1982年 | 690篇 |
1981年 | 646篇 |
1980年 | 499篇 |
1979年 | 649篇 |
1978年 | 576篇 |
1977年 | 561篇 |
1976年 | 488篇 |
1972年 | 462篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
Chih-Wei Hsu Sheng-Yu Lee Yao-Hsu Yang Liang-Jen Wang 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2020,23(10):653
BackgroundGeneric antidepressants are approved on the market based on evidence of bioequivalence to their brand-name versions. We aimed to assess whether generic antidepressants exert equal effectiveness as their brand-name counterparts for treating patients with depressive disorders.MethodsIn a nationwide, population-based cohort in Taiwan from 1997 through 2013, patients with a diagnosis of a depressive disorder aged between 18 and 65 years who were new users of antidepressant drugs were classified into either the brand-name group or the generic group. All patients were followed up until medication discontinuation or the end of the study period. We assessed the risk for hospitalization as a primary outcome and augmentation therapy, daily dose, medication discontinuation, or switching to another antidepressant as secondary outcomes.ResultsA total of 277 651 brand-name users (35.8% male; mean age: 41.2 years) and 270 583 generic users (35.8% male; mean age: 41.0 years) were divided into 10 different antidepressant groups (fluoxetine, sertraline, paroxetine, escitalopram, citalopram, venlafaxine, mirtazapine, moclobemide, imipramine, and bupropion). We found that patients treated with the generic form of sertraline, paroxetine, escitalopram, venlafaxine, mirtazapine, and bupropion demonstrated significantly higher risks of psychiatric hospitalization (adjusted hazard ratios ranged from 1.20–2.34), compared to their brand-name counterparts. The differences between brand-name antidepressants and their generic counterparts in secondary outcomes varied across different drugs.ConclusionsCompared to most generic antidepressants, brand-name drugs exhibited more protective effects on psychiatric hospitalization for depressive patients. These findings could serve as an important reference for clinicians when encountering patients with depressive disorder. 相似文献
73.
74.
A mixed‐method study of effects of a therapeutic play intervention for children on parental anxiety and parents' perceptions of the intervention 下载免费PDF全文
75.
76.
77.
78.
Haya Mohammed BSc MChB M. Yousuf Salmasi MRCS Massimo Caputo PhD Gianni D. Angelini PhD Hunaid A. Vohra PhD 《Journal of cardiac surgery》2020,35(6):1209-1219
Background
Limited data exists demonstrating the efficacy of minimally invasive surgery (MIS) compared to median sternotomy (MS) for multiple valvular disease (MVD). This systematic review and meta-analysis aims to compare operative and peri-operative outcomes of MIS vs MS in MVD.Methods
PubMed, Ovid, and Embase were searched from inception until August 2019 for randomized and observational studies comparing MIS and MS in patients with MVD. Clinical outcomes of intra- and postoperative times, reoperation for bleeding and surgical site infection were evaluated.Results
Five observational studies comparing 340 MIS vs 414 MS patients were eligible for qualitative and quantitative review. The quality of evidence assessed using the Newcastle-Ottawa scale was good for all included studies. Meta-analysis demonstrated increased cardiopulmonary bypass time for MIS patients (weighted mean difference [WMD], 0.487; 95% confidence interval [CI], 0.365-0.608; P < .0001). Similarly, aortic cross-clamp time was longer in patients undergoing MIS (WMD, 0.632; 95% CI, 0.509-0.755; P < .0001). No differences were found in operative mortality, reoperation for bleeding, surgical site infection, or hospital stay.Conclusions
MIS for MVD have similar short-term outcomes compared to MS. This adds value to the use of minimally invasive methods for multivalvular surgery, despite conferring longer operative times. However, the paucity in literature and learning curve associated with MIS warrants further evidence, ideally randomized control trials, to support these findings.79.
80.
Factors predicting the development of pressure ulcers in an at‐risk population who receive standardized preventive care: secondary analyses of a multicentre randomised controlled trial 下载免费PDF全文